Investeringsoversigt

8247 investments

Titel Sort descending	Periode	Program
Talegenkendelse hjælper børn med at lære at læse og skaber nye interaktive læseoplevelser	2016 - 2017	Innobooster
Talegenkendelse hjælper børn med at lære at læse og skaber nye interaktive læseoplevelser Period 2016 - 2017 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 30.97 Invested 458.400 Budget 1.5 mill. Partners Knowlge ApS People Maneno ApS Read more about the project
Talenthub Navigator	2021 - 2022	Innobooster
Talenthub Navigator Period 2021 - 2022 Region Region Nordjylland Program Innobooster Area Ikke defineret Investment Percentage 31.16 Invested 434.362 Budget 1.4 mill. Partners TalentHub.io A/S People TalentHub.io A/S Read more about the project
Talkherd: AI-understøttet moderation af verbale angreb	2022 - 2023	Innobooster
Talkherd: AI-understøttet moderation af verbale angreb Period 2022 - 2023 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 35 Invested 998.900 Budget 2.9 mill. Partners Analyse Og Tal FMBA People ANALYSE OG TAL F.M.B.A Read more about the project
Talking Ninja 3, Maj 2017	2017 - 2019	Innobooster
Talking Ninja 3, Maj 2017 Period 2017 - 2019 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33.07 Invested 487.812 Budget 1.5 mill. Partners Talking Ninja IVS People Talking Ninja IVS Read more about the project
Talmo Genkendelse Af Reservedele Med Kunstig Intelligens	2018 - 2018	Innobooster
Talmo Genkendelse Af Reservedele Med Kunstig Intelligens Period 2018 - 2018 Region Region Nordjylland Program Innobooster Area Ikke defineret Investment Percentage 10.46 Invested 131.225 Budget 1.3 mill. Partners Talmo People Talmo ApS Read more about the project
Tandsundhed og machine learning	2019 - 2020	Innobooster
Tandsundhed og machine learning Period 2019 - 2020 Region Region Hovedstaden Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 29.64 Invested 495.000 Budget 1.7 mill. Partners Adent ApS People Adent ApS Read more about the project
Tange & Partners i Vækstsporet	2018 - 2019
Tange & Partners i Vækstsporet Period 2018 - 2019 Region Region Syddanmark Program Area Handel, Service og Samfund Investment Percentage 100 Invested 150.000 Budget 150.000 Partners TANGE & PARTNERS ApS People TANGE & PARTNERS ApS Read more about the project
TapTraQ mobilapps projekt	2016 - 2017	Innobooster
TapTraQ mobilapps projekt Period 2016 - 2017 Region Region Nordjylland Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 162.112 Budget 491.250 Partners TapTraQ ApS People TapTraQ ApS Read more about the project
Target discovery using machine learning approaches in cardiometabolic disease	2021 - 2024	Industrial Researcher
Target discovery using machine learning approaches in cardiometabolic disease Period 2021 - 2024 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 48.88 Invested 1.2 mill. Budget 2.5 mill. Partners University of Copenhagen, Novo Nordisk A/S People Novo Nordisk A/S Read more about the project
Target identification platform for discovery of receptors for orphan ligands	2020 - 2023	Industrial Researcher
Target identification platform for discovery of receptors for orphan ligands Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners Københavns Universitet, Novo Nordisk A/S - E1 People Novo Nordisk A/S - E1 Read more about the project
TARGET – Therapeutic Aptamer-Reformulated Glioblastoma Treatment	2025 - 2026	Innoexplorer
TARGET – Therapeutic Aptamer-Reformulated Glioblastoma Treatment Period 2025 - 2026 Region Program Innoexplorer Area Ikke defineret Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners Danmarks Tekniske Universitet People Danmarks Tekniske Universitet Read more about the project
Targeted Auger radiotherapy: A new drug class to cure glioblastoma	2021 - 2022	Innoexplorer
Targeted Auger radiotherapy: A new drug class to cure glioblastoma Period 2021 - 2022 Region Region Hovedstaden Program Innoexplorer Area Ikke defineret Investment Percentage 100 Invested 1.5 mill. Budget 1.5 mill. Partners Danmarks Tekniske Universitet People Danmarks Tekniske Universitet Read more about the project
Targeted Multiple Sclerosis therapy using a novel genetically engineered innate immune cell differentiated from pluripotent stem cells	2024 - 2027	Industrial Researcher
Targeted Multiple Sclerosis therapy using a novel genetically engineered innate immune cell differentiated from pluripotent stem cells Period 2024 - 2027 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 39.78 Invested 1.1 mill. Budget 2.7 mill. Interferon beta (IFNb) var det første godkendte lægemiddel til behandling af den neurodegenerative sygdom Multipel Sklerose. Denne og andre aktuelle behandlinger har dog en række bivirkninger. Vi vil udvikle en celleterapi baseret på plasmacytoide dendritcellers (pDC'er) unikke immun-regulerende evner. Det vil vi gøre ved at producere pDC'er fra stamceller og genetisk manipulere disse til at producere og frigive IFNb lokalt efter binding til et specifikt antigen på demyelinerede neuroner. Partners Aarhus University, UNIKUM Therapeutics ApS People Read more about the project
Targeting adenylate cyclase 3 (ADCY3) to promote anorexigenic signaling in the treatment of obesity	2020 - 2023	Industrial Researcher
Targeting adenylate cyclase 3 (ADCY3) to promote anorexigenic signaling in the treatment of obesity Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.1 mill. Budget 1.1 mill. Partners University of Copenhagen, Novo Nordisk A/S - G8, x9 m.fl. People Novo Nordisk A/S - G8, x9 m.fl. Read more about the project
Targeting breast cancer associated HERV-K: Finalizing clinical regimen and prognosticators for clinical studies	2020 - 2023	Industrial Researcher
Targeting breast cancer associated HERV-K: Finalizing clinical regimen and prognosticators for clinical studies Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Copenhagen, INPROTHER ApS People INPROTHER ApS Read more about the project